The role of sildenafil in the treatment of stroke.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Current opinion in investigational drugs

• Publication date

  2008-07-01

• Fields of study

  Medicine

• Identifiers
  PMID 18600581
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2008cited by this paper
• Neuroplasticity and brain repair after stroke

  2008cited by this paper
• Recombinant human erythropoietin in the treatment of human brain disease: focus on cognition.

  2008cited by this paper
• Stroke treatment—light at the end of the tunnel?

  2007cited by this paper
• Acute Ischemic Stroke Treatment in 2007

  2007cited by this paper
• Angiogenesis and improved cerebral blood flow in the ischemic boundary area detected by MRI after administration of sildenafil to rats with embolic stroke.

  2007cited by this paper
• Blockade of phosphodiesterase Type 5 enhances rat neurohypophysial excitability and electrically evoked oxytocin release

  2007cited by this paper
• Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.

  2007cited by this paper
• Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke.

  2006cited by this paper
• Sildenafil Improves Dynamic Vascular Function in the Brain: Studies in Patients with Pulmonary Hypertension

  2006cited by this paper
• Newborn neurons may help heal brain after stroke

  2006cited by this paper
• Recovery in a Patient with Locked-In Syndrome

  2006cited by this paper
• Cellular and molecular mechanisms of neural repair after stroke: Making waves

  2006cited by this paper
• Neurorepair versus Neuroprotection in Stroke

  2006cited by this paper
• Evidence for stroke-induced neurogenesis in the human brain

  2006cited by this paper
• Delayed treatment with sildenafil enhances neurogenesis and improves functional recovery in aged rats after focal cerebral ischemia

  2006cited by this paper
• Phosphodiesterase 5 inhibitor, zaprinast, selectively increases cerebral blood flow in the ischemic penumbra in the rat brain

  2005cited by this paper
• Functional Recovery in Aged and Young Rats After Embolic Stroke: Treatment With a Phosphodiesterase Type 5 Inhibitor

  2005cited by this paper
• Activation of the PI3-K/Akt Pathway Mediates cGMP Enhanced-Neurogenesis in the Adult Progenitor Cells Derived from the Subventricular Zone

  2005cited by this paper
• Past, present, and future: a 7‐year update of Viagra® (sildenafil citrate)

  2005cited by this paper
• Sildenafil increases cerebrovascular reactivity: A transcranial Doppler study

  2005cited by this paper
• The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion

  2004cited by this paper
• Nogo Receptor Antagonism Promotes Stroke Recovery by Enhancing Axonal Plasticity

  2004cited by this paper
• Effect of sildenafil (Viagra) on cerebral blood flow velocity: a pilot study.

  2003cited by this paper
• mRNA expression patterns of the cGMP‐hydrolyzing phosphodiesterases types 2, 5, and 9 during development of the rat brain

  2003cited by this paper
• Neurogenesis and brain injury: managing a renewable resource for repair.

  2003cited by this paper
• Nitric Oxide Enhances Angiogenesis via the Synthesis of Vascular Endothelial Growth Factor and cGMP After Stroke in the Rat

  2003cited by this paper
• Sildenafil (Viagra) Induces Neurogenesis and Promotes Functional Recovery After Stroke in Rats

  2002cited by this paper
• Coronary and systemic hemodynamic effects of sildenafil citrate: from basic science to clinical studies in patients with cardiovascular disease.

  2002cited by this paper
• Localization of Phosphorylated cAMP Response Element-Binding Protein in Immature Neurons of Adult Hippocampus

  2002cited by this paper
• The Phosphodiesterase 5 Inhibitor Sildenafil Has No Effect on Cerebral Blood Flow or Blood Velocity, but Nevertheless Induces Headache in Healthy Subjects

  2002cited by this paper
• A nitric oxide donor induces neurogenesis and reduces functional deficits after stroke in rats

  2001cited by this paper
• Immunohistochemical Localization of cGMP-binding cGMP-specific Phosphodiesterase (PDE5) in Rat Tissues

  2000cited by this paper
• Sympathetic Activation by Sildenafil

  2000cited by this paper
• Recovery recapitulates ontogeny.

  2000cited by this paper
• Pathobiology of ischaemic stroke: an integrated view.

  1999cited by this paper
• Rising stroke rates spur efforts to identify risks, prevent disease.

  1998cited by this paper
• Expression of neuronal nitric oxide synthase during embryonic development of the rat cerebral cortex.

  1998cited by this paper
• Neurogenesis in the adult human hippocampus

  1998cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1996cited by this paper
• Sildenafil: an orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction.

  1996cited by this paper
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper
• Age‐related production of new granule cells in the adult dentate gyrus

  1995cited by this paper
• Nitric oxide: a physiologic messenger molecule.

  1994cited by this paper
• Tissue plasminogen activator in acute stroke.

  1993cited by this paper
• Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

  1987cited by this paper
• Autoradiographic and histological evidence of postnatal hippocampal neurogenesis in rats

  1965cited by this paper

• Glial Cell Reprogramming in Ischemic Stroke: A Review of Recent Advancements and Translational Challenges

  2025cites this paper
• Sildenafil reduced neuroinflammation and improved white matter injury in a rat model of term neonatal hypoxic-ischemic encephalopathy

  2025cites this paper
• Cerebral stroke-induced neurogenesis: insights and therapeutic implications

  2024cites this paper
• The Role of Sildenafil in Treating Brain Injuries in Adults and Neonates

  2022cites this paper
• Sildenafil improves hippocampal brain injuries and restores neuronal development after neonatal hypoxia–ischemia in male rat pups

  2021cites this paper
• Restorative Therapies after Stroke: Drugs, Devices, and Robotics

  2019cites this paper
• Modern Concepts in Regenerative Therapy for Ischemic Stroke: From Stem Cells for Promoting Angiogenesis to 3D-Bioprinted Scaffolds Customized via Carotid Shear Stress Analysis

  2019cites this paper
• Treatments to Promote Neural Repair after Stroke

  2018cites this paper
• 59 – Interventions to Improve Recovery after Stroke

  2016cites this paper
• Sildenafil, a cyclic GMP phosphodiesterase inhibitor, induces microglial modulation after focal ischemia in the neonatal mouse brain

  2016cites this paper
• Phosphodiesterase-5 Inhibitor PF-03049423 Effect on Stroke Recovery: A Double-Blind, Placebo-Controlled Randomized Clinical Trial.

  2016cites this paper
• Sildenafil Improves Functional and Structural Outcome of Retinal Injury Following Term Neonatal Hypoxia-Ischemia.

  2016cites this paper
• Sildenafil Improves Brain Injury Recovery following Term Neonatal Hypoxia-Ischemia in Male Rat Pups

  2016cites this paper
• Sungshim-san-mediated Recovery of Cognition and Motor Function in the Severe Rat Stroke, Permanent Middle Cerebral Artery Occlusion Model

  2015cites this paper
• Recent Results In Phosphodiesterase Inhibitor Development and CNS Applications

  2014cites this paper
• Effects of daily low-dose treatment with phosphodiesterase type 5 inhibitor on cognition, depression, somatization and erectile function in patients with erectile dysfunction: a double-blind, placebo-controlled study

  2014cites this paper
• Targeting nitric oxide in the subacute restorative treatment of ischemic stroke

  2013cites this paper
• A non-brain penetrant PDE5A inhibitor improves functional recovery after stroke in rats

  2012cites this paper
• Neurorestoration therapeutics for neurodegenerative and psychiatric disease

  2012cites this paper
• Partial motor restoration upon administration of sildenafil: a case study

  2012cites this paper
• Molecular and cellular mechanisms underlying the role of blood vessels in spinal cord injury and repair

  2012cites this paper
• Influence of sildenafil on the anticonvulsant action of selected antiepileptic drugs against pentylenetetrazole-induced clonic seizures in mice

  2012cites this paper
• Effects of repeated dosing with Udenafil (Zydena) on cognition, somatization and erection in patients with erectile dysfunction: a pilot study

  2011influential citation
• ildronate treatment improves functional recovery following middle cerebral rtery occlusion in rats

  2011cites this paper
• Sildenafil promotes smooth muscle preservation and ameliorates fibrosis through modulation of extracellular matrix and tissue growth factor gene expression after bilateral cavernosal nerve resection in the rat.

  2011cites this paper
• KMUP-1 attenuates serum deprivation-induced neurotoxicity in SH-SY5Y cells: roles of PKG, PI3K/Akt and Bcl-2/Bax pathways.

  2010cites this paper
• PDE5 inhibitors and their applications.

  2010cites this paper
• Angiogenesis, neurogenesis and brain recovery of function following injury.

  2010cites this paper
• Novel therapeutic targets for hypertension

  2010cites this paper
• Treatment with sildenafil prevents impairment of learning in rats born to pre-eclamptic mothers.

  2010cites this paper
• Blood Pressure Lowering Effects of a New Long-Acting Inhibitor of Phosphodiesterase 5 in Patients With Mild to Moderate Hypertension

  2009cites this paper
• Phosphodiesterase 5A Inhibitors Improve Functional Recovery after Stroke in Rats: Optimized Dosing Regimen with Implications for Mechanism

  2009influential citation
• Phosphodiesterase-5 Blood Pressure Lowering Effects of a New Long-Acting Inhibitor of Phosphodiesterase 5 in Patients With Mild to Moderate Hypertension

  2009cites this paper